Since the outbreak of Covid-19, many people have recovered from the after-effects of this deadly disease.
And there had been an instance that those people are immune for several months afterward.
But the recent outburst of the second wave of the corona has created havoc in everyone’s life.
The new cases of Covid-19 are increasing rapidly at astonishing rates globally. Around 1.2 billion people have recently developed infestation in the second wave of Covid-19. And almost a total of 561,356 deaths have been reported in the prior week.
Despite the continuous track record of the patient, keeping the exact count of reinfection, serious cases, and hospital admission rates is quite tough for healthcare professionals and researchers.
Among all the challenges, keeping the reinfection count is a big concern for authorities.
Over the last year, the repeated infection with Covid-19 has shaken the confidence in the immune system’s ability to sustain the Covid-19 virus for a longer period.
However, the data suggest that reinfection is very rare, it occurred in lesser than 3% of about 6600 patients who had been already infected with Covid-19.
Some of these infections get evaluated but researchers are still unable to keep a full record of reinfected Covid-19 patients.
There is a lot that is missing from the eyes of scientists and researchers. And that is a lack of information or data that is hindering the research process of scientists. So what are the concerns researchers are having? And how can they cope with this brimming situation? Let’s discuss the same in detail.
Issues Researchers’ are facing due to the lack of data:
As per the study till date and the data available , first infection with coronavirus develops immunity that lasts for 4-6 months ,hence reduces the chance of Covid-19 reinfection to some extent. But , that surely varies from a person to person as per their immunity levels. Some people develops immunity that may not be strong enough to fight the second infection . But, in maximum cases as per the study, 4% of patients recorded for reinfections with mild symptoms , to 2% being asymptomatic. However, on a wider note according to a report, 80% of people under the age of 65 might get the covid reinfection.
But due to the failure of Healthcare system Survillance , very little information is retrieved about the people who got infected first time, their symptoms were severe or mild, and what was the duration of their symptoms onset & decline.
And on top of that researchers don’t have any data except for the test results which pushes them saying that without better data , we can’t claim that how rare are Covid-19 reinfections ?
Furthermore, this much information is not enough to figure out the cause of Covid-19 reinfection and how can one cope with this situation and whether the covid-19 reinfection is still rare or not .
Here are some of the challenges experts are facing in the deep analysis and study of Covid-19 reinfection?
- Limited Data On Covid-19 Reinfection
Across the world, all the countries are floundered with the most basic public health procedure. According to a report around 18 % of people who are covid positive unable to provide the details of close contact through which they get infection And this data is taken after a long duration of the first covid-19 wave. Moreover, the reason for this limited data is an underfunded health care system that is ill-equipped to respond. And in reality, these failures are occurring at every stage of test, trace, and isolate sequence. Due to this unpredictability scientists are struggling to figure out the possible difference between the first and second infection and how severe the second reinfection could get for the person.
- No Track Record of Covid-19 Reinfection
With the increasing instances of Covid-19 reinfection, authorities and governments are struggling to keep digital surveillance in check. It might look like a negative approach bur surveillance is an essential tool to responding the emergencies.
But policymakers and authorities are making a tough choice on deciding whether they should invoke extraordinary surveillance or not.
As a result, this lack of testing and monitoring is resulting in a large number of covid reinfection with no prior information on the source of infection. There is a need for an automated system that can keep the track record of Covid-19 reinfection and how frequently it is happening.
- Lack of Patient Symptoms data
The notion of reinfection has added a new twist in the ongoing Covid-19 battle. With no track record of particular patient symptoms, scientists and researchers are unable to figure out for how long the protection lasts for a covid-19 infection. Moreover, the data on multiple factors such as age, duration of reinfection, whether the symptoms were mild or severe, and asymptomatic infection are still missing. All these factors combined have raised the concern regarding the course of action that authorities have to take in the Covid-19 reinfection response. There is an urgent need to bring transparency in covid 19 reinfection tracking so that science and researchers can plan how and where to divert their research to control the outbreak.
- Unavailability of Vaccine trials data
As a scientist, you might be interested more in getting actual data from a clinical trial to know what is the actual interpretation of the results. Moreover, researchers are also concerned that with the unavailability of vaccine trial data, patients are getting an incomplete picture of vaccine success that whether it is effective in the treatment of mild or severe covid infection. And without having enough data scientists are struggling to figure out how many patients are getting benefitted from the vaccine and how many are not showing a sign of recovery. This is raising serious concern for scientists in figuring out their next course of action in vaccine trials.
Contact us for Global Healthcare data & Analytics
Above all, Scientists and researchers are looking for data and analytics that could help them in figuring out what went wrong and how to cope with the uncertainty that comes with Covid-19 reinfection. In simple words, better Data & Analytics are the need of the hour. Only with enough data and track records researchers would be able to expedite the Vaccine development process and contribute towards the results related to Covid-19 Reinfections.